A Study to Evaluate Immunity to Varicella Zoster Virus After Immunization With V212 Vaccine or Zostavax (V212-003)

NCT00886613 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: V212
BIOLOGICAL: Comparator: Zostavax™
BIOLOGICAL: Comparator: Placebo
OTHER: VZV Skin Test
OTHER: Saline

Sponsor

Merck Sharp & Dohme LLC